|
|
||||||||

*
Section of Cardiovascular Sciences, DeBakey Heart Center and Department of Medicine, Methodist Hospital, Baylor College of Medicine, Houston, TX 77030;
Spiros P. Martel Laboratory of Leukocyte Biology, Department of Pediatrics, Texas Childrens Hospital, Houston, TX 77030
Numerous studies have shown that polymorphonuclear neutrophils
(PMNs) infiltrate the myocardium immediately after reperfusion of
infarcted tissue. Studies with mAbs in vivo and cellular studies in
vitro suggest that PMN-induced injury of the cardiac myocyte involve
Mac-1 adhesion to myocyte ICAM-1. In this study we demonstrate that
PMNs that have infiltrated the ischemic area begin to lose Mac-1 within
the first 3 h. By the fifth hour of reperfusion, minimal CD11b
staining is seen on PMNs using immunostaining, whereas CD11a remained
unchanged. Immunoreactivity of postreperfusion cardiac lymph with R15.7
(anti-CD18) or MY904 (anti-CD11b) was positive in all animals
but not for CD11a (R7.1), indicating a specific loss of Mac-1.
Immunoprecipitation with either R15.7 or MY904 resulted in identical
peptides (a doublet at 190 kDa and a band at 80 kDa), suggesting that
both
and ß subunits of Mac-1 heterodimer were released.
Immunoprecipitation of control PMN lysates revealed bands of 198 kDa
and 91 kDa slightly greater than those from the released Mac-1. An in
vitro model of homotypic aggregation showed a similar loss of Mac-1
from PMNs; immunoprecipitates of the supernatant demonstrated peptide
bands identical with those found in postischemic cardiac lymph. The
appearance of soluble Mac-1 in vitro was prevented by anti-CD18
mAb, R15.7, and also by protease inhibition by PMSF. Thus, in vivo and
in vitro, activated PMNs lose Mac-1 in a process that may be dependent
upon adhesion and subsequent proteolysis.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |